[ad_1]
Shares of Five Below Inc. slid after hours Tuesday, after the teen-centered discount retailer said its chief executive had stepped down and that it forecasts further downbeat sales for the second quarter as shoppers continue to deal with the impacts of inflation.
[ad_2]
Source link
FDA approves Eli Lilly’s weight loss drug Zepbound for sleep apnea
An Eli Lilly & Co. Zepbound injection pen arranged in the Brooklyn borough of New York, US, on Thursday, March...